Bristol Myers Squibb said Wednesday it will enroll more patients in a key Phase 3 trial studying its drug Cobenfy in psychosis associated with Alzheimer’s disease, after the company found “irregularities due to clinical trial execution” at a small number of study sites. After consulting with the Food and Drug Administration, Bristol had an independent…
Use of head CT scans in ERs more than doubles over 15 years: Study We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Driving Pattern Changes Help Detect Early Cognitive Decline: Study We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
GLP-1 agonists have been shown to be beneficial in a lengthening list of diseases, but it seems Alzheimer’s disease may not be among them. Novo Nordisk has just released the topline findings from two eagerly anticipated phase 3 trials of its oral formulation of GLP-1 drug semaglutide, with the deeply disappointing news that the drug…
Prospects for Bayer’s oral Factor XIa inhibitor asundexian were looking speculative when it failed a phase 3 trial in atrial fibrillation (AF), but new data in secondary stroke prevention could get the programme back on track. The results of the OCEANIC-STROKE study reveal that asundexian was more effective than placebo when given on top of…
Who is more likely to lose vision due to high brain pressure? We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Few primary care practices are designed for the timely detection of Alzheimer’s disease and related dementias. The limited time that primary care clinicians are able to spend with patients, the need to focus on the health problems which brought the patient to the clinic, as well as the stigma of Alzheimer’s disease and dementia are…
Heavy alcohol use linked to risk of brain bleed earlier in life, states study We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
Study links heart attacks and late-onset epilepsy in older adults We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok Source link
A smartphone app for muscle relaxation significantly reduced migraine-related disability in patients visiting the emergency department, a new study shows. Led by researchers from NYU Langone Health, the study featured a smartphone-based app that guides patients with migraine through progressive muscle relaxation (PMR), an evidence-based treatment for migraine in which patients tense and then relax…